Conmed Corporation (CNMD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Conmed Corporation  (NYSE: CNMD)


Conmed's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Conmed's ROI in the second quarter of 2026?
Conmed Corporation achieved a return on average invested assets (ROI) of 2.66 % in its second quarter of 2026, this is above CNMD's average return on investment of 2.45%.
Conmed Corporations investments during the 12 months ending in the second quarter of 2026 are valued at $2 billion

ROI fell compared to the first quarter of 2026, despite the net income growth of 66.84% from the first quarter of 2026.

Within the Healthcare sector 156 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1947 to 1995.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 6.55 % 1.3 % 3.03 % 2.64 % 3.25 %
Y / Y Net Income Change TTM -48.73 % -53.81 % -58.25 % -18.86 % 267.61 %
Investment (TTM) in Millions 2,533 1,941 2,011 2,008 2,034
Return On Investment (TTM) 2.66 % 2.74 % 2.33 % 3.2 % 5.53 %
CNMD's Overall Ranking # 1995 # 1947 # 1142 # 1536 # 1107
Seq. Investment Change TTM 6.24 % -0.91 % 0.71 % 0.5 % 1.01 %
Seq. Net Income Change TTM 3.01 % 16.56 % -26.56 % -41.86 % -7.2 %
Net Income (TTM) in Millions 56 55 47 64 110

CNMD Company Profile >> Back to CNMD Roi Comparisons >> See Annual CNMD Return On Investment



Return On Investment CNMD's Ranking
Within: No.
Industry # 52
Sector # 157
Overall # 1995

Return On Investment Statistics
High Average Low
6.54 %
2.45 %
-6.89 %
(Dec 31 2024)   (Jun 30 2022)







Financial Statements
Conmed's II. Quarter Investments $ 2,533 Millions CNMD's Balance sheet
Conmed's II. Quarter Income $ 23 Millions Quarterly CNMD's Income Statement
CNMD's Income by Division See CNMD's Income by Division


CNMD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,931 1,954 1,928 1,934 1,501
Y / Y Investment Growth -1.17 % 1.33 % -0.31 % 28.88 % -0.18 %
Net Income in Millions 47 132 64 -81 63
Y / Y Net Income Growth -64.47 % 105.44 % - - 557.16 %
Annual Return On Investment 2.44 % 6.78 % 3.34 % -4.17 % 4.17 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 2.44 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CNMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CNMD's Competitors
Subscribers only: Roi for Conmed's Suppliers
Subscribers only: Return On Investment for CNMD's Customers

Other Ratios
CNMD's Roa CNMD's Inventory Turnover Ratio CNMD's Growth Rates CNMD's Dividend Statistics
CNMD's Profitability Ratios CNMD's Asset Turnover Ratio CNMD's Dividend Growth
CNMD's Roe CNMD's Valuation Ratios CNMD's Financial Strength Ratios CNMD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Davita Inc   6.92 %
Kewaunee Scientific Corporation  6.58 %
Medtronic Plc  6.46 %
Siga Technologies Inc  6.45 %
Labcorp Holdings Inc   6.11 %
Royalty Pharma Plc  6.09 %
Pacs Group Inc   5.86 %
Merit Medical Systems Inc  5.80 %
Ensign Group Inc  5.75 %
Nrc Health  5.72 %
IMPACT BIOMEDICAL INC.  5.68 %
Vericel Corporation  5.58 %
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %

Date modified: 2026-08-13T05:53:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.